Frontlight ResearchEarly access
Trial site
Guangdong Provincial Perople's Hospital
- 5running trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Brain metastases1 trial
- Phase
- Phase 23 trials
- Phase 41 trial
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Guangdong Association of Clinical Trials5 trials
Running trials
Not yet recruiting
Recruiting
Active, not recruiting
Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Recruiting
Lorlatinib as the First-line Treatment in China Advanced ALK+ NSCLC
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026